Study of PAH Subjects With LTOT Use That Have Demonstrated Improved Exercise Tolerance With the Use of Inhaled Nitric

NCT03602781 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Decision not to proceed with Study

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: Placebo
DRUG: iNO

Sponsor

Bellerophon Pulse Technologies

Collaborators

[object Object]